Summary

At present, Elea manufactures and markets products belonging to different therapeutic groups. These products are also exported to various countries.

We constantly try to establish business relations with companies all over the world, with the specific purpose of providing our clients with products of the highest possible quality.

Elea information

• Present in the Argentine Pharmaceutical market since 1939.
• Sales Force: 220 Representatives.
• Presence in the institutional market not audited by IMS.

Business Areas

Female Health Division
Focussed on three main groups: Osteoporosis, Contraceptives and Hormone Replacement therapy.

Antiinfectives and General Line Division
Covers mainly Antibiotics and Anti-virals, Anti-inflamatories and Analgesics, Antiacids, Anti-Histamines and Antihaemorroidal products.

Biotechnology and Vaccines Division
Agrippal S1 (Subunit Influenza Vaccine); Menjugate (Meningoccocal C Conjugate vaccine); Tetanol (Tetanus Vaccine).

Neuropsiquiatric Division
Its main focus is Anti-epileptic, Anti-depresion, Anti-psicotic products. New developments in treatment of Alzheimer disease.

Cardiology Division
Covers mainly the areas of Lipid reducing agents, Antihypertensives, Potassium-Sparing products, Antiplatelet therapies and Oral Antidiabetic therapies.

Metabolism Division
Focussed on three main groups: Anticoagulant, Obesity and Oral Antidiabetics.

AIDS Division
This new business area started Operating as from 1997.

Over the counter products
A wide range of laxative products, wash mouths, dermatologic products, pregnancy test, antacids.

Back Top